SEC Filing Details

Document Details

Filing Date
Apr 1, 1996
Document Date
Dec 31, 1995
Form Description
Annual report. The Regulation S-K Item 405 box on the cover page is checked
Filing Group
Annual Filings
Company
Celldex Therapeutics
Issuer
CELLDEX THERAPEUTICS, INC.

About us

Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. Our pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response.

 

Our Pipeline